1-8 of 8
Suzette Blanchard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from a Phase 1 Study to Evaluate a Memory-Enriched CD19-Specific CAR T Cell Platform in Adult Patients with CD19+ B-Cell Non-Hodgkin Lymphoma (B-NHL)

Tanya Siddiqi, Xiuli Wang, M. Suzette Blanchard, Jamie Wagner, Vibhuti Vyas, Mary C. Clark, Sandra Thomas, Baishakhi Barva, Angelica Gamez, Leslie L. Popplewell, Alex F. Herrera, Elizabeth Budde, Liana Nikolaenko, Christine E Brown, Stephen J Forman
Journal: Blood
Blood (2021) 138 (Supplement 1): 2836.
https://doi.org/10.1182/blood-2021-147082
Published: 2021
Journal Articles

CD19-CAR Therapy Using Naive/Memory or Central Memory T Cells Integrated into the Autologous Stem Cell Transplant Regimen for Patients with B-NHL

Leslie Popplewell, MD, Xiuli Wang, PhD, Suzette Blanchard, PhD, Jamie Wagner, BS, Araceli Naranjo, BS, Arencibia Adria, BS, Jinny Paul, PhD, Laura Lim, Wen-Chung Chang, PhD, Elizabeth E Budde, MD PhD, Sandra Thomas, PhD, Christine Brown, PhD, Stephen J Forman
Journal: Blood
Blood (2018) 132 (Supplement 1): 610.
https://doi.org/10.1182/blood-2018-99-119650
Published: 2018
Journal Articles

Adult Patients with ALL Treated with CD62L+ T Naïve/Memory-Enriched T Cells Expressing a CD19-CAR Mediate Potent Antitumor Activity with a Low Toxicity Profile

Samer K. Khaled, MD, Suzette Blanchard, PhD, Xiuli Wang, PhD, Jamie Wagner, BS, Araceli Naranjo, BS, Jennifer Simpson, Sandra Thomas, PhD, Julie Ostberg, PhD, Christine Brown, PhD, Stephen J Forman
Journal: Blood
Blood (2018) 132 (Supplement 1): 4016.
https://doi.org/10.1182/blood-2018-99-119883
Published: 2018
Journal Articles

Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

Lihua Budde, MD PhD, Joo Y Song, MD, Young Kim, MD, Suzette Blanchard, PhD, Jamie Wagner, BS, Anthony S. Stein, MD, Lihong Weng, MD, Marissa Del Real, PhD, Rochelle Hernandez, Emanuela Marcucci, Jennifer K Shepphird, PhD, Xiuli Wang, PhD, Brent Wood, MDPhD, Guido Marcucci, MD, Christine E Brown, PhD, Stephen J. Forman, MD FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 811.
https://doi.org/10.1182/blood.V130.Suppl_1.811.811
Published: 2017
Journal Articles

Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Clinical Trials & Observations
Xiuli Wang, Leslie L. Popplewell, Jamie R. Wagner, Araceli Naranjo, M. Suzette Blanchard, Michelle R. Mott, Adam P. Norris, ChingLam W. Wong, Ryan Z. Urak, Wen-Chung Chang, Samer K. Khaled, Tanya Siddiqi, Lihua E. Budde, Jingying Xu, Brenda Chang, Nikita Gidwaney, Sandra H. Thomas, Laurence J. N. Cooper, Stanley R. Riddell, Christine E. Brown, Michael C. Jensen, Stephen J. Forman
Journal: Blood
Blood (2016) 127 (24): 2980–2990.
https://doi.org/10.1182/blood-2015-12-686725
Published: 2016
Includes: Supplemental data
Journal Articles

Phase I Studies of Cellular Immunotherapy Using Central Memory Derived-CD19-Specific T Cells Following Autologous Stem Cell Transplantation for Patients with High-Risk Intermediate Grade B-Lineage Non-Hodgkin Lymphoma

Leslie Popplewell, MD, Xiuli Wang, PhD, Araceli Naranjo, BS, Suzette Blanchard, PhD, Jamie Wagner, BS, ChingLam Wong, BS, Ryan Urak, MS, Wen-Chung Chang, MS, Samer K Khaled, MD, Tanya Siddiqi, MD, Elizabeth E. Budde, MD PhD, Jingying Xu, PhD, Brenda Chang, BS, Sandra H. Thomas, PhD, Stanley R. Riddell, MD, Christine Brown, PhD, Michael C Jensen, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2015) 126 (23): 930.
https://doi.org/10.1182/blood.V126.23.930.930
Published: 2015
Journal Articles

A Phase I Study of the HDAC Inhibitor LBH589 in Combination with Imatinib for Patients with CML in Cytogenetic Remission with Residual Disease Detectable by Q-PCR.

Ravi Bhatia, David S. Snyder, Allen Lin, Jennifer Arceo, Linda Seymour, Michael Deininger, Jerald Radich, Suzette Blanchard, Stephen Forman
Journal: Blood
Blood (2009) 114 (22): 2194.
https://doi.org/10.1182/blood.V114.22.2194.2194
Published: 2009
Journal Articles

Iron Overload Adversely Affects Survival and Increases Risk of Graft-Versus-Host Disease and Blood Stream Infections after Allogeneic Hematopoietic Stem Cell Transplantation.

Vinod Pullarkat, MD, Suzette Blanchard, PhD, Bernard Tegtmeier, PhD, Andrew Dagis, MS, Kathryn Patane, RN, James Ito, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2007) 110 (11): 2981.
https://doi.org/10.1182/blood.V110.11.2981.2981
Published: 2007